Mycoplasma Testing Market to Deliver Greater Revenues During the Forecast Period Until 2027: Thermo Fisher Scientific, Lonza Group Ltd., Merck KGaA
According to the current analysis of Reports and Data, the global Mycoplasma Testing market size was valued at USD 609.39 million in 2019 and is expected to reach USD 1.59 billion by year 2027, at a CAGR of 12.6%. Mycoplasma is the smallest known species of bacteria, that has developed due to the de-generative evolution from Gram-positive bacteria. Mycoplasma bacterial cell has missing cell wall and can either be saprotrophic or parasitic. In spite of there being nearly 200 different...
View full press release